Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Current HIV Research|September 15, 2012
Substance abuse, HIV-1 and hepatitisNirzari Parikh, Michael R Nonnemacher, Vanessa Pirrone, et al.Frontiers in Microbiology|January 22, 2016
Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseMonique E Maubert, Vanessa Pirrone, Nina T Rivera, et al.Virology Journal|June 3, 2014
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site ISonia Shah, Aikaterini Alexaki, Vanessa Pirrone, et al.Journal of Biomedicine & Biotechnology|July 1, 2010
A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infectionVanessa Pirrone, Shendra Passic, Brian Wigdahl, et al.Clinical Medicine Insights. Pathology|May 5, 2017
cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor CellsAnupam Banerjee, Luna Li, Vanessa Pirrone, et al.Future Virology|April 19, 2013
Impact of age on markers of HIV-1 diseaseVanessa Pirrone, David J Libon, Christian Sell, et al.Advances in Virology|August 18, 2012
Impact of Tat Genetic Variation on HIV-1 DiseaseLuna Li, Satinder Dahiya, Sandhya Kortagere, et al.Clinical Medicine Insights. Pathology|November 23, 2017
Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start SiteYujie Liu, Michael R Nonnemacher, Aikaterini Alexaki, et al.Journal of Biomedicine & Biotechnology|December 2, 2011
Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine modelKarissa Lozenski, Tina Kish-Catalone, Vanessa Pirrone, et al.Traffic (Copenhagen, Denmark)|May 1, 2018
Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenterAnthony R Mele, Jamie Marino, Kenneth Chen, et al.Pageof 5